CSI Market
Sign In | Register

Alnylam Pharmaceuticals Inc (ALNY) Annual Balance Sheets

Annual · GAAP · USD millions
Access ALNY quarterly Balance Sheets →
Examining balance sheet movements between Alnylam Pharmaceuticals Inc and Dec 31 2021 reveals how Dec 31 2025 adjusts its asset composition and liability profile.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent1,657.25
Available-for-sale Securities, Debt Securities, Current MA1,251.23
Cash & Short-term Investments2,908.00
Accounts receivable777.57
Inventories82.72
Other Current Assets0.00
Prepaid Expense And Other Assets Current281.89
Total Current Assets4,050.66
Equipment/Property/Plant Net513.15
Long-term investments22.17
Other Assets, Noncurrent402.52
Equity Securities Fv Ni-
Operating Lease Right Of Use Asset194.92
Total Assets4,966.33
Liabilities
Accounts Payable, Current AC115.72
Accrued Liabilities, Current AC1,080.20
Other Liabilities, Current270.43
Total Current Liabilities1,466.35
Long-term debt0.00
Secured Debt-
Convertible Debt, Noncurrent LO1,007.78
Total Long-term Debt1,007.78
Other liabilities, Noncurrent1,703.02
Operating Lease Liability Current45.52
Operating Lease Liability Noncurrent225.09
Contract With Customer Liability Noncurrent-
Total Liabilities4,177.16
Stockholders' Equity
Common Stock Value1.32
Additional Paid In Capital Common Stock7,510.47
Retained Earnings / Accumulated Deficit-6,702.52
Other Equity-20.10
Common Stockholder's Equity789.18
Total Stockholder's Equity789.18
Liabilities & Stockholder's Equity4,966.33
4 historic quarters locked

Sign in to unlock the full Alnylam Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Alnylam Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 12, 2026
  • Source: alny-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-007497

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License